Sperling Prostate Center

What Transrectal Ultrasound Can’t Do

An Important Update on the Rise in Post-Biopsy Infections
When multiparametric MRI goes head-to-head against transrectal ultrasound (TRUS), it continues to demonstrate clear seniority in detecting clinically significant prostate cancer. Although conventional grayscale ultrasound can provide better results when combined with additional power using b-mode or Doppler USS, newer technologies continue to be developed. These include... keep reading

Artificial Intelligence in Medicine: AI Confounded by Contaminated Prostate Cancer Tissue

Designing a Virtual Prostate Biopsy Using MRI Scans
I’ve posted numerous blogs on the promising applications of Artificial Intelligence (AI) in the medical world. Early research and development of Machine Learning (ML) and Deep Learning (DL) show results that offer accuracy rivaling that of humans, and speed/efficiency no human can begin to approach. This all sounds glorious! However, as AI tools have become keep reading

A New Treatment for Metastatic Prostate Cancer

Coping with Prostate Cancer
Metastatic prostate cancer is considered incurable. There are new chemotherapies, PCa vaccines and immunotherapies that can add months to a patient’s life. The disappointing news is that mPCa eventually overcomes these treatments—and for many patients, the side effects can be harsh. Now there’s Pluvicto, an intravenous treatment that delivers a radioactive punch to individual mPCa cells... keep reading
WordPress Image Lightbox